Table 1 Characteristics of participants.

From: A device for surveillance of vascular access sites for bleeding: results from a clinical evaluation trial

Characteristic

All (n = 250)

Reference range

Insertion of non-tunnelled catheter

20 (8.0%)

Insertion of tunnelled catheter

157 (62.8%)

Removal of non-tunnelled catheter

38 (15.2%)

Removal of tunnelled catheter

35 (14.0%)

Days before removal (non-tunnelled)

5 (4–7)

Days before removal (tunnelled)

98 (22–208)

Sex (female)

110 (44.0%)

Age (years)

65 (55–73)

Serum urea (mmol/L)

21.6 (15.5–27.3)

2.8–7.7

Serum creatinine (umol/L)

608 (439–817)

Females: 50–90; males: 65–125

eGFR (mL/min/1.73m2)

7 (5–9)

> 90

International normalized ratio

0.99 (0.95–1.07)

0.8–1.1

Partial thromboplastin time (s)

29.9 (26.9–33.6)

30–40

Platelet count (× 103/μL)

209 (159–274)

140–400

  1. Quantitative variables are presented as median (interquartile range); qualitative variables are presented as n (%).
  2. eGFR estimated glomerular filtration rate.